Related Experiment Videos

[Relationship of Chinese medicine syndrome pattern with heart function and brain natriuretic peptide in patients with

Hui Li1, Shu-Yun Xie, Wei-Xing Lu

  • 1Department of Cardiology, Dongfang Hospital Affiliated to Beijing University of Chinese Medicine, Beijing. lihui8832@163.com

Insights

Chinese medicine syndrome patterns correlate with heart function in heart failure (HF) patients. Left ventricular ejection fraction (LVEF) and brain natriuretic peptide (BNP) levels can objectively assess HF severity and aid in syndrome differentiation.

Area of Science:

  • Integrative Medicine
  • Cardiology
  • Traditional Chinese Medicine

Background:

  • Heart failure (HF) management benefits from understanding its diverse presentations.
  • Traditional Chinese Medicine (TCM) categorizes HF into distinct syndrome patterns.
  • Objective markers are needed to correlate TCM patterns with Western medical assessments.

Purpose of the Study:

  • To investigate the relationship between TCM syndrome patterns and cardiac function in HF patients.
  • To evaluate ultrasonic cardiography (USCG) parameters and brain natriuretic peptide (BNP) levels as indicators of HF severity within TCM patterns.

Main Methods:

  • 116 HF inpatients were classified into three TCM syndrome groups: qi-yin deficiency (QYD), qi-deficiency and blood-stasis (QDBS), and yang-deficiency with water overflowing (YDWO).
  • USCG parameters (LVEDs, LVEDd, LVEF) and serum BNP levels were measured for all participants.
  • Statistical analysis was performed to determine correlations between TCM patterns and cardiac function markers.

Main Results:

  • Left ventricular ejection fraction (LVEF) decreased and BNP levels increased progressively across the TCM patterns in the order: QYD → QDBS → YDWO (P < 0.01).
  • TCM syndrome patterns showed significant correlations with all USCG parameters and BNP levels.
  • BNP (r = 0.71) and LVEF (r = -0.34) demonstrated particularly strong associations with TCM syndrome patterns (P < 0.05).

Conclusions:

  • LVEF and BNP levels serve as valuable objective and quantitative indices for assessing heart failure severity.
  • These cardiac function markers can effectively aid in the differentiation of TCM syndrome patterns in heart failure patients.
Abstract

Related Concept Videos

Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Heart Failure VII: Nursing Interventions01:30

Heart Failure VII: Nursing Interventions

The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...